HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months

被引:84
作者
Edghill, Emma L.
Dix, Rachel J.
Flanagan, Sarah E.
Bingley, Polly J.
Hattersley, Andrew T.
Ellard, Sian
Gillespie, Kathleen M.
机构
[1] Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England
[2] Univ Bristol, Dept Clin Sci N Bristol, Bristol, Avon, England
基金
英国惠康基金;
关键词
D O I
10.2337/db06-0094
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Children with permanent diabetes are usually assumed to have type 1 diabetes. It has recently been shown that there are genetic subgroups of diabetes that are often diagnosed during the neonatal period but may present later. A recent Italian study proposed that type I diabetes is rare before 6 months of age. We aimed to examine genetic susceptibility to type 1 diabetes in patients diagnosed with diabetes before the age of 2 years. We analyzed HLA class 11 genotypes, markers of autoimmune diabetes, in 187 children with permanent diabetes diagnosed at < 2 years of age. Of the 79 subjects diagnosed at < 6 months of age, 41% (95% CI 0.30-0.51) had type 1 diabetes-associated high-risk genotypes, a proportion similar to that in healthy population control subjects (44%, P = 0.56). This group included 32 patients with mutations in the KCNJ11 gene, which encodes Kir6.2 (44% high-risk HLA class 11 genotypes), and 47 in whom the etiology of diabetes was unknown (38% high-risk HLA class 11 genotypes). Of 108 patients diagnosed between 6 and 24 months of age, 93% (0.86-0.99) had high-risk HLA class 11 genotypes compared with 44% of the population control subjects (P < 0.0001). We conclude that infants diagnosed with diabetes before 6 months of age are unlikely to have autoimmune type 1 diabetes and are most likely to have a monogenic etiology.
引用
收藏
页码:1895 / 1898
页数:4
相关论文
共 22 条
[1]   Prediction of IDDM in the general population - Strategies based on combinations of autoantibody markers [J].
Bingley, PJ ;
Bonifacio, E ;
Williams, AJK ;
Genovese, S ;
Bottazzo, GF ;
Gale, EAM .
DIABETES, 1997, 46 (11) :1701-1710
[2]   DIABETES DIAGNOSED BEFORE THE AGE OF 2 YEARS - MORTALITY IN A BRITISH COHORT 8-17 YEARS AFTER ONSET [J].
BOTHA, JL ;
PARKER, H ;
RAYMOND, NT ;
SWIFT, PGF .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1992, 21 (06) :1132-1137
[3]   High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation [J].
Codner, E ;
Flanagan, S ;
Ellard, S ;
García, H ;
Hattersley, AT .
DIABETES CARE, 2005, 28 (03) :758-759
[4]  
Devendra Devasenan, 2003, Journal of Allergy and Clinical Immunology, V111, pS624
[5]   Activating mutations in the KCNJ11 gene encoding the ATP-sensitive K+ channel subunit Kir 6.2 are rare in clinically defined type 1 diabetes diagnosed before 2 years [J].
Edghill, EL ;
Gloyn, AL ;
Gillespie, KM ;
Lambert, AP ;
Raymond, NT ;
Swift, PG ;
Ellard, S ;
Gale, EAM ;
Hattersley, AT .
DIABETES, 2004, 53 (11) :2998-3001
[6]  
FLANAGAN SE, 2005, DIABETIC MED, V22, P10
[7]   Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the β-cell potassium adenosine triphosphate channel [J].
Gloyn, AL ;
Cummings, EA ;
Edghill, EL ;
Harries, LW ;
Scott, R ;
Costa, T ;
Temple, IK ;
Hattersley, AT ;
Ellard, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08) :3932-3935
[8]   Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes [J].
Gloyn, AL ;
Pearson, ER ;
Antcliff, JF ;
Proks, P ;
Bruining, GJ ;
Slingerland, AS ;
Howard, N ;
Srinivasan, S ;
Silva, JMCL ;
Molnes, J ;
Edghill, EL ;
Frayling, TM ;
Temple, IK ;
Mackay, D ;
Shield, JPH ;
Sumnik, Z ;
van Rhijn, A ;
Wales, JKH ;
Clark, P ;
Gorman, S ;
Aisenberg, J ;
Ellard, S ;
Njolstad, PR ;
Ashcroft, FM ;
Hattersley, AT .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (18) :1838-1849
[9]   Activating mutations in Kir6.2 and neonatal diabetes - New clinical syndromes, new scientific insights, and new therapy [J].
Hattersley, AT ;
Ashcroft, FM .
DIABETES, 2005, 54 (09) :2503-2513
[10]   The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease [J].
Hattersley, AT ;
Tooke, JE .
LANCET, 1999, 353 (9166) :1789-1792